Overview

Effects of Metformin During Nicotine Withdrawal

Status:
Completed

Trial end date:
2020-03-13

Target enrollment:

Participant gender:

Summary

The purpose of this study is to test the effects of a medication called metformin (Glucophage®) on smoking behavior. This medication is FDA-approved for treatment of type-2 diabetes. It is being used for research purposes in this study. Participants will be randomized to one of 3 treatment groups: low dose of metformin, high dose of metformin, or placebo.

Phase:

Phase 2

Details

Lead Sponsor:

University of Pennsylvania

Collaborator:

Pennsylvania Department of Health

Treatments:

Metformin
Nicotine